Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration sort icon Public title Sponsor State
10/02/2017 Cuban uterine manipulator, new device for the hysterectomy totally laparoscopic. CNCMA Registered
10/05/2018 Oncoxin-Viusid/Stomach and gastric esophagus union cancer / Adults / Phase II CATALYSIS Registered
10/06/2021 SOBERANA PEDIATRIA FINLAY Registered
10/07/2018 A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer. ROCHE Registered outdated
10/09/2020 Biomodulin T in older adult for protection in events of local transmission of COVID-19 BIOCEN Registered
10/11/2014 CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized. CIGB Registered
10/11/2021 Expanded Clinical Use of Nasalferon in COVID-19 CIGB Registered outdated
11/03/2016 Biograft-G in Dentistry BIOMAT Registered
11/03/2016 Dermofural-diabetic foot ulcers CBQ Registered
11/03/2021 Phyisician Led CIMAvax-EGF lung biomarkers CIM Registered outdated
11/03/2021 CIGB2020- ARI elderly contacts CIGB Registered outdated
11/05/2021 Doxycycline for prostate cancer SSA Registered
11/06/2018 Usual treatment plus intra-articular application of bioactive formulation for osteoarthritis SSA Registered
11/08/2020 DALIA Study CIGB Registered outdated
11/08/2020 CIMAvax-EGF in Bladder cancer CIM Registered outdated
11/09/2014 NeuroEPO-Stroke. Phase I-II CIMAB Registered
11/10/2013 Randomized double blind controlled, phase I clinical trial, to assess safety, reactogenicity and immunogenicity of the 638 vaccine candidate, in healthy female and male children and adolescents aged from 5 to 17 years old from Cienfuegos Province, Cuba. FINLAY Registered
12/03/2019 A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer ROCHE Registered
12/05/2015 Vitamin E/ Platinum salts CIDEM Registered
12/05/2020 Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab CIM Registered outdated